Viewing Study NCT00333112


Ignite Creation Date: 2025-12-26 @ 11:10 AM
Ignite Modification Date: 2026-01-22 @ 2:16 PM
Study NCT ID: NCT00333112
Status: COMPLETED
Last Update Posted: 2014-09-18
First Post: 2006-06-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate Solifenacin Succinate in Combination With Tamsulosin for the Treatment of Residual Overactive Bladder Symptoms (OAB) in Men.
Sponsor: Astellas Pharma Inc
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Urinary Incontinence View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Treatment Outcome View
None Urology View
None Solifenacin succinate View
None Urinary Incontinence View